| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-596 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-731
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-26 |
| filingDate |
2020-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7839f2ef2f6ac6a79c777de0a3593d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1c1c1e1f682449cb491e10aabe9d89d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_552a84d5068e61008491064329b8b9fd |
| publicationDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021039721-A1 |
| titleOfInvention |
Oral composition |
| abstract |
Provided is an oral composition capable of suppressing irritation caused by a water-soluble aluminum salt and imparting a highly astringent feeling. This oral composition contains (A) a water-soluble aluminum salt and (B) a cationic polymer compound, wherein the content of the component (A) is 0.1-0.5% by mass in terms of aluminum ions, and {the amount of aluminum ions of the (A) component}/(B) is 0.23-5 in terms of mass ratio. Said oral composition further contains any component among: (C) at least one selected from among a nonionic surfactant (C-1) and a betaine-type amphoteric surfactant (C-2); (D) an anti-inflammatory component; (E) xanthan gum; (F) at least one selected from among silica, calcium carbonate, and calcium phosphate; and (G) a water-soluble fluorine compound. |
| priorityDate |
2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |